Back to top
more

Establishment Labs (ESTA)

(Delayed Data from NSDQ)

$48.54 USD

48.54
212,618

-0.41 (-0.84%)

Updated Apr 25, 2024 04:00 PM ET

After-Market: $48.59 +0.05 (0.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value F Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (80 out of 251)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Establishment Labs Holdings Inc. (ESTA) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 16.84% and 0.06%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Establishment Labs Holdings Inc. (ESTA) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -55.56% and 5.71%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Establishment Labs Holdings Inc. (ESTA) Soars 7.8%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Strength Seen in Establishment Labs Holdings Inc. (ESTA): Can Its 14.3% Jump Turn into More Strength?

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 4.41% and 2.78%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Brookdale (BKD) May 2023 Occupancy Rises: Better Days Ahead?

by Zacks Equity Research

Brookdale (BKD) has witnessed 19 straight months of year-over-year increases in weighted average occupancy level.

Humana (HUM) Arm Reaches 250 Senior Primary Care Facilities

by Zacks Equity Research

Humana's (HUM) CenterWell business focuses on providing a better healthcare experience through clubbing primary care, home health and pharmacy services.

Should You Retain Acadia Healthcare (ACHC) in Your Portfolio?

by Zacks Equity Research

Acadia Healthcare's (ACHC) top line is likely to receive support from growth in specialty treatment and acute inpatient psychiatric facilities.

Encompass Health (EHC) to Build New Hospital in Concordville

by Zacks Equity Research

The new inpatient rehabilitation unit is likely to be the 10th hospital of Encompass Health (EHC) in Pennsylvania.

HCA Healthcare (HCA) to Acquire 41 Urgent Care Centers in Texas

by Zacks Equity Research

HCA Healthcare (HCA) expects the acquisition of urgent care centers from FastMed to close by this summer.

Here's Why Hold Strategy is Apt for Centene (CNC) Stock Now

by Zacks Equity Research

Centene's (CNC) health benefit ratio is estimated at 87.1-87.7% for 2023, signaling better operating efficiency.

Should You Hold on to Teladoc Health (TDOC) Stock for Now?

by Zacks Equity Research

Teladoc Health's (TDOC) cash-generating abilities are boosted by the growing number of visits and memberships.

Humana (HUM) Teams Up With DME Entities to Boost Home Solutions

by Zacks Equity Research

These partnerships will equip Humana (HUM) with the means to deploy advanced clinical programs that can reduce hospitalizations for the members.

Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 33.33% and 1.69%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Surgalign Holdings (SRGA) Q1 Earnings Expected to Decline

by Zacks Equity Research

Surgalign (SRGA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Establishment Labs Holdings Inc. (ESTA) Stock Jumps 6.1%: Will It Continue to Soar?

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Derek Lewis headshot

What's Going On With Block Shares?

by Derek Lewis

Block shares are making headlines for all the wrong reasons today, with short-seller Hindenburg Research raising red flags surrounding the company. Whose side are you on?

Does Establishment Labs Holdings Inc. (ESTA) Have the Potential to Rally 43.03% as Wall Street Analysts Expect?

by Zacks Equity Research

The average of price targets set by Wall Street analysts indicates a potential upside of 43% in Establishment Labs Holdings Inc. (ESTA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Wall Street Analysts Predict a 42.71% Upside in Establishment Labs Holdings Inc. (ESTA): Here's What You Should Know

by Zacks Equity Research

The mean of analysts' price targets for Establishment Labs Holdings Inc. (ESTA) points to a 42.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Establishment Labs Holdings Inc. (ESTA) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of -55.10% and 1.85%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

GoodRx Holdings, Inc. (GDRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

GoodRx Holdings, Inc. (GDRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Establishment Labs Holdings Inc. (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.